Fondazione Policlinico Universitario A. Gemelli IRCCS — Roma, RM

Public research footprint of Fondazione Policlinico Universitario A. Gemelli IRCCS, compiled from the ClinicalTrials.gov public registry.

379

Registered studies

220

Active

124

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Becker Muscular Dystrophy · Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) · Crohn Disease · Hemolytic Disease of the Fetus and Newborn

Recently updated registry entries

NCT07215273 — Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy (Recruiting)
NCT06982521 — Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for… (Recruiting)
NCT06788756 — L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Fondazione Policlinico Universitario A. Gemelli IRCCS?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.